ENTELLUS MED INC - COM (ENTL)

CUSIP: 29363K105

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
13,667,356
Share change
+397,296
Total reported value
$259,249,973
Price per share
$18.97
Number of holders
63
Value change
+$7,294,126
Number of buys
35
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 29363K105?
CUSIP 29363K105 identifies ENTL - ENTELLUS MED INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ENTELLUS MED INC - COM (ENTL) as of Q4 2016

As of 31 Dec 2016, ENTELLUS MED INC - COM (ENTL) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,667,356 shares. The largest 10 holders included Essex Woodlands Health Ventures, Inc., SV Life Sciences Advisers, LLC, Discovery Group I, LLC, FMR LLC, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, First Light Asset Management, LLC, WELLS FARGO & COMPANY/MN, Cortina Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and Arrowpoint Asset Management, LLC. This page lists 63 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.